| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 75,364 | 55,696 |
| Stock-based compensation | 63,732 | 40,853 |
| Accretion of marketable securities | -4,010 | -3,005 |
| Depreciation and amortization | 860 | 571 |
| Deferred income taxes | -22,355 | -31,469 |
| Non-cash amortization of right-of-use asset | 548 | 360 |
| Trade receivables | 15,653 | 10,591 |
| Insurance recovery receivable related to melucci litigation | 0 | 0 |
| Inventory | 7,964 | 4,021 |
| Prepaid expenses and other current assets | 15,693 | 2,232 |
| Other assets | 1,439 | 1,693 |
| Accounts payable | 19,070 | 8,149 |
| Accrued research and development expenses | -5,546 | -4,819 |
| Accrued and other liabilities | 17,164 | 6 |
| Accrued settlement related to melucci litigation | 0 | 0 |
| Long-term accrued income taxes | 48 | 1,593 |
| Operating lease liability | -578 | -331 |
| Net cash provided by operating activities | 103,548 | 49,067 |
| Purchases of property and equipment | 161 | 161 |
| Proceeds from sales and maturities of marketable securities | 257,536 | 205,536 |
| Purchases of marketable securities | 175,774 | 138,419 |
| Net cash provided by (used in) investing activities | 81,601 | 66,956 |
| Proceeds from stock option exercises, net of issuance costs | 13,008 | 10,975 |
| Proceeds from purchases under the employee stock purchase program | 7,160 | 4,990 |
| Repurchases of common stock in connection with stock repurchase program | 172,915 | 130,451 |
| Cash paid to satisfy statutory withholding requirement for net settlement of cashless option exercises and vesting of restricted stock grants | 36,403 | 28,251 |
| Net cash used in financing activities | -189,150 | -142,737 |
| Net effect of exchange rate changes on cash and cash equivalents | 1,474 | 1,794 |
| Net (decrease) increase in cash and cash equivalents | -2,527 | -24,920 |
| Cash and cash equivalents at beginning of period | 127,665 | - |
| Cash and cash equivalents at end of period | 125,138 | - |
CORCEPT THERAPEUTICS INC (CORT)
CORCEPT THERAPEUTICS INC (CORT)